Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cells

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2557-2560

  Kuramitsu, Yasuhiro ^a   Tominaga, Waka ^a   Baron, Byron ^a   Tokuda, Kazuhiro ^a   Wang, Yufeng ^a   Kitagawa, Takao ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

DDX39; DEAD box RNA helicase; Malignant pleural mesothelioma

Indexed keywords

DEAD BOX PROTEIN; DEAD BOX PROTEIN 39; TUMOR MARKER; UNCLASSIFIED DRUG; DDX39A PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESOTHELIUM CELL; PLEURA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING; DDX39; DEAD-BOX RNA HELICASE; LUNG TUMOR; MESOTHELIOMA; METABOLISM; PLEURA TUMOR; TUMOR CELL LINE;

DDX39; DEAD-BOX RNA HELICASE; MALIGNANT PLEURAL MESOTHELIOMA;

CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

MLCS; MLOWN;

EID: 84881395753     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Robinson BW, Musk AW, and Lake RA: Malignant mesothelioma. Lancet 366: 397-408, 2005.
2. Mossman B and Gee J: Asbestos-related diseases. N Engl J Med 320: 1721-1730, 1989.
3. Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med 353: 1591-1603, 2005.
4. Peto J, Hodgson JT, Matthews FE and Jones JR: Continuing increase in mesothelioma mortality in Britain. Lancet 345: 1535-539, 1995.
5. Kuramitsu Y, Miyamoto H, Tanaka T, Zhang X, Fujimoto M, Ueda K, Tanaka T, Hamano K and Nakamura K: Proteomic differential display analysis identified up-regulated astrocytic phsphoprotein PEA-15 in human malignant pleural mesothelioma cell lines. Proteomics 9: 5078-5089, 2009.
6. Sugiura T, Sakurai K and Nagano Y: Intracellular characterization of DDX39, a novel growth-Associated RNA helicase. Exp Cell Res 313: 782-790, 2007.
7. Cruz J, Kressler D and Linder P: Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 24: 192-198, 1999.
8. Rocak S and Linder P: DEAD-box proteins: The driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 5: 232-241, 2004.
9. Yoo HN and Chung IK: Requirement of DDX39 DEAD box RNA helicase for genome integrity and telomere protection. Aging Cell 10: 557-571, 2011.
10. Sugiura T, Nagano Y and Noguchi Y: DDX39, up-regulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biol Ther 6: 957-964, 2007.
11. Kikuta K, Kubota D, Saito T, Orita H, Yoshida A, Tsuda H, Suehara Y, Katai H, Shimada Y, Toyama Y, Sato K, Yao T, Kaneko K, Beppu Y, Murakami Y, Kawai A and Kondo T: Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics 75: 1089-1098. 2012.
12. Kubota D, Okubo T, Saito T, Suehara Y, Yoshida A, Kikuta K, Tsuda H, Katai H, Shimada Y, Kaneko K, Kawai A and Kondo T: Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour. Jap J Clin Oncol 42: 730-741, 2012.
13. Kato M, Wei M, Yamano S, Kakehashi A, Tamada S, Nakatani T and Wanibuchi H: DDX39 acts as a suppressor of invasion for bladder cancer. Cancer Sci 103: 1363-1369, 2012.
14. Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Down-regulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 29: 2651-2659, 2008.
15. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuriya K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K and Sakaida I: Proteomics finding heat-shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
16. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Taba K, Fujimoto M, Okita K, Nakamura K and Sakaida I: A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines. Mol Med Rep 1: 429-434, 2008.
17. Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M and Nakamura K: Proteomic differential display analysis shows up-regulation of 14-3-3 protein sigma in human scirrhous-type gastric carcinoma cells. Anticancer Res 30: 4459-4465, 2010.
18. Kuramitsu Y, Hayashi E, Okada F, Tanaka T, Zhang X, Ueyama Y and Nakamura K: Proteomic analysis for nuclear proteins related to tumour malignant progression: A comparative proteomic study between malignant progressive cells and regressive cells. Anticancer Res 30: 2093-2099, 2010.
19. Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Akad JK, Wang Y, Toda T, Sakaida I, Okita K, Oka M and Nakamura K: Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res 31: 3331-3336, 2011.